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Background: The assessment of Health Related Quality of Life (HRQOL) has been applied as a significant outcome
indicator for patients with chronic diseases. No HRQOL study, however, has looked at HRQOL in patients with
chronic gastritis and peptic ulcers. This paper focuses on comparing HRQOL in patients with chronic gastritis and
peptic ulcers and examining the factors that influence the HRQOL of such patients. Results can be used for making
decisions in clinical trials as well as aiding individual management and preventive care of these diseases.
Methods: The Chinese version of the SF-36 (CSF-36) was administered twice to 244 patients with chronic gastritis
and peptic ulcers. Mean scores across the two disease groups were compared using t-tests, change over time was
analyzed with paired samples t-tests, and factors predicting HRQOL were investigated using the univariate general
linear model.
Results: The mean domain scores of patients with chronic gastritis were lower than those for patients with peptic
ulcers, with the exception of physical functioning. Both groups had lower HRQOL compared with population
norms. Mean domain scores increased after treatment in both groups. HRQOL in patients with these two chronic
diseases differed by age, education level, marriage, income, and gender, but their explanatory power was relatively
low.
Conclusion: Quality of life of patients with chronic gastritis was lower than that of patients with peptic ulcers,
which was lower than population norms. Quality of life in both patients groups was associated with
socio-demographic risk factors.
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Diseases of the digestive system such as gastritis, func-
tional gastrointestinal disorders, and peptic ulcers are
common throughout the world [1-3]. While these are
not generally life-threatening conditions, they can sig-
nificantly impair patients’ quality of life (QOL). These
digestive system diseases are important to public health
because they are remarkably common, can hinder a* Correspondence: wanchh@hotmail.com; lpg27548742@163.com
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reproduction in any medium, provided the orperson’s daily activities, and can cause major social and
economic burden. Peptic ulcer disease (PUD) affects as
many as 10% of people in the United States at some point
during their life, and the annual cost of treatment in the
United States alone has been estimated at $5.7 billion [1].
Thus, there is a substantial impact of these diseases on
public health.
In the last 30 years, health–related quality of life
(HRQOL) has become an important outcome measure for
patients with cancer and chronic diseases. The Medical
Outcomes Study 36-items Short-Form Health Survey
(SF-36) has been widely used as a HRQOL instrument
[4,5] and is also being used with greater frequency inter-
nationally. The SF-36 has been translated into manyd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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as part of the International Quality of Life Assessment
(IQOLA) project [5].
In China, research on HRQOL has sharply increased
since the 1980s. The simplified Chinese (Mandarin) ver-
sion of SF-36 (CSF-36) was rigorously developed using
forward and backward translation and has demonstrated
good reliability and validity in the Chinese general popu-
lation [6]. More specifically, a three-stage protocol was
followed including translation, tests of scaling con-
struction and scoring assumptions, and validation and
normalization. A total of 1688 respondents were recruited
by multi-stage mixed sampling in 1000 households in 18
communities of Hangzhou. The results showed the clus-
tering and ordering of item means was the same as that of
the source survey. The item-scale correlations were identi-
cal for all except the social functioning and vitality scales;
convergent validity and discriminant validity were satisfac-
tory for all except the social functioning scale. In addition,
Cronbach’s α coefficients ranged from 0.72 to 0.88, with
the exception of 0.39 for the social functioning scale and
0.66 for the vitality scale, and two weeks test-retest re-
liability coefficients ranged from 0.66 to 0.94. The trans-
lated survey was also able to distinguish between known
groups. It was concluded that the Chinese (mainland)
version of the SF-36 functioned in the general popula-
tion quite similarly to the original American population
tested [6].
In addition, the CSF-36 was validated among patients
with chronic diseases including hypertension, coronary
heart disease, chronic gastritis and peptic ulcers in China
[7]. In this longitudinal study, the CSF-36 was used in a
sample of 534 patients from these four chronic disease
groups, and the psychometric properties of the scale were
evaluated by indicators such as Cronbach’s α, Pearson’s r,
standardized response mean employing correlational ana-
lyses, multi-trait scaling analysis, t-tests, factor analyses,
and structural equation models. It was concluded that the
CSF-36 showed good validity and reliability but low re-
sponsiveness when used in patients, and it is a relatively
useful instrument for patients with chronic disease when
no specific instruments are available [7].
Worldwide, while there have been a few studies that
used the SF-36 to measure HRQOL in patients with
peptic ulcers [8-10], to date, there have been no studies
which have compared HRQOL in patients with chronic
gastritis and peptic ulcers using the SF-36. In a study
conducted by Hallerbäck et al. [11], the Psychological
General Well-Being Index (PGWB) was administrated to
1526 patients with esophagitis (192), gastric ulcers (109),
duodenal ulcers (426), duodenitis/gastritis (296), nega-
tive endoscopy (401) and other diagnoses (102) before
endoscopy. All five patient groups, excluding the other
group, reported low general well-being compared to thegeneral population; however, no differences emerged be-
tween the groups. On the other hand, in a study by
Mokrowiecka et al. which used the SF-36, differences
in HRQOL were found between patients with three
common gastroenterological chronic conditions: gastro-
esophageal reflux disease (GERD), peptic ulcer disease
(PUD) and ulcerative colitis (UC). Bodily pain measured
by SF-36 was significantly lower in GERD and PUD than
those with UC [8]. Therefore, we expect that SF-36 will
allow the detection of different quality of life among
patients with peptic ulcers and patients with chronic
gastritis. We hope to fill a void in the literature by com-
paring these clinically similar diseases in an attempt to
identify and explain differences in HRQOL outcomes.
These results may be influential in making decisions in
clinical trials as well as in aiding in the individual ma-
nagement of these diseases.
The goals of the present study are to (1) compare
HRQOL using CSF-36 in patients with chronic gastritis
and peptic ulcers, (2) compare HRQOL between both
groups of patients and population norms, (3) determine
the influence factors of HRQOL in these populations,
and (4) compare HRQOL change over time and explore




Participants consisted of 244 inpatients with either
chronic gastritis or peptic ulcers at the First Affiliated
Hospital of Kunming Medical University. They were
diagnosed primarily through endoscopy and gastric bi-
opsy but also through gastrointestinal symptoms such as
abdominal pain, bloating, and other symptoms of these
two diseases. If any patients had both diseases, they were
classified according to their primary diagnosis. All pa-
tients were considered for inclusion, but it was required
that they were able to read, understand, and complete
the questionnaires. Patients who were illiterate and those
with advanced disease status were therefore excluded
from participation.
Measure
The CSF-36 contains 36 items which represent eight do-
mains: physical functioning (PF), role-physical (RP), bodily
pain (BP), general health (GH), vitality (VT), social func-
tioning (SF), role-emotional (RE), and mental health (MH).
These domains can be further aggregated into a physical
components summary (PCS) and a mental components
summary (MCS), or an overall index if needed (see
Figure 1) [12]. Specifically, all domain scores and the two
component summaries are linearly converted into a 0–100
scale using the following formula: SS = (RS-Min) × 100/R,
where SS, RS, Min, and R represent the standardized score,
Figure 1 The conceptual structure of SF-36 (From Ware JE Jr et al.).
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tively, with higher scores representing better HRQOL [12].
Survey method
After obtaining appropriate institutional review board ap-
proval of Kunming Medical University, the investigators
described the study and the scale to the patients and
obtained informed consent from patients who agreed to
participate and met the inclusion criteria. Participants
completed the CSF-36 (paper format) at the time of ad-
mission and at the time of discharge. Information regar-
ding socio-demographic and clinical variables such as age,
gender, and education was collected through medical re-
cords and the face page of our questionnaire.
Statistical analysis
Domain scores for each of the two diseases were com-
pared using t-tests. Independent samples t-tests were used
to compare the mean scores for each domain and sum-
mary variables of the CSF-36 at admission across the two
disease groups. In addition, independent samples t-tests
were used to compare differences in each domain between
the two disease groups. The change of HRQOL scores
from admission to discharge was evaluated in severaldifferent ways: with a paired sample t-test for each domain
of the CSF-36 separately for each disease, with a change
ratio (CR, the difference between the two divided by the
baseline means), and with a standardized response mean
(SRM) [13,14], used to reflect the degree of change. Of
them, SRM was used as a measure of effect size, with
values of 0.20, 0.50 and 0.80 representing small, moderate
and large responsiveness respectively [13,14].
In order to investigate what socio-demographic and dis-
ease type factors may influence HRQOL, the univariate
general linear model was used with the information ga-
thered at the time of admission (due to the larger sample
size). PCS and MCS scores were used as the dependent
variable respectively (backward selection with p-value
in = 0.05 and p-value out = 0.10), and age as the covariate.
The categorical independent variables were recoded be-
fore analysis as follows: gender (1 =male, 2 = female),
marriage (1 =married, 2 = other), education (1 = primary
school, 2 = high school, 3 = college or higher), ethnicity
(1 =Han, 2 = other), medical security (1 = self-pay or
partly-pay, 2 = public insurance), occupation (1 = factory
worker, 2 = other occupations), disease type (1 = chronic
gastritis, 2 = peptic ulcer). Finally, the univariate general
linear model was used to analyze HRQOL score change
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change as the dependent variable respectively and factors
above as independent variables.
Results
Socio-demographic characteristics of the study
population
Table 1 summarizes the socio-demographic variables of
interest in the current sample. Of the 244 patients who
completed measures at admission, 124 had been diagnosedTable 1 Socio-demographic characteristics of the sample
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Public insurance 66 53.2with chronic gastritis and 120 had been diagnosed with
peptic ulcers. Ages ranged 16 to 79, with a median age of
44.5 and mean (±SD) age of 45.2 (±15.4). A majority of
the patients were of Han ethnicity (86.9%), male (58.2%)
and married (85.2%). Forty-five patients (18.4%) had fi-
nished primary school, while 119 (48.8%) had completed
high school, and 80 (32.8%) had a college degree. Of those
who completed the admission measures, 84.4% (206) also
completed the measures at discharge (chronic gastritis,
peptic ulcers).Peptic ulcer (N = 120) Total (N = 244)
n % n %
82 68.3 142 58.2
38 31.7 102 41.8
105 87.5 208 85.2
15 12.5 36 14.8
18 15 46 18.9
19 15.8 51 20.9
27 22.5 44 18.0
32 26.7 55 22.5
24 20.0 48 19.7
46.7 ± 15.2
104 86.7 212 86.9
16 13.3 32 13.1
21 17.5 45 18.4
62 51.7 119 48.8
37 30.8 80 32.8
46 38.3 82 33.6
14 11.7 28 11.5
14 11.7 24 9.8
18 15 43 17.6
28 23.3 67 27.5
35 29.2 60 24.6
71 59.2 158 64.8
14 11.7 26 10.7
41 34.2 92 37.7
6 5 13 5.3
73 60.8 139 57.0
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At admission, the data from 244 patients (124 chronic
gastritis and 120 peptic ulcers) were used to analyze
HRQOL across diseases. As shown in Table 2 and Figure 2,
most domains (with the exception of RP, BP, SF and PCS)
exhibited statistically significance differences between the
two disease groups. The patients with peptic ulcers had
higher mean scores than those with chronic gastritis for
most domains, with the exception of PF (where patients
with chronic gastritis had higher scores).
In addition, based on the data from 206 patients (104
chronic gastritis and 102 peptic ulcers), mean scores for
each domain and summary variable of the CSF-36 at dis-
charge were compared (see Table 2). Only VT, MH, and
MCS were significantly different between the two groups,
with scores for patients with peptic ulcers being higher
than those of patients with chronic gastritis.
HRQOL comparisons between patients and population
norms
Work conducted in China with a community-based sam-
ple of 1688 showed mean domain scores of PF 82.2 ± 19.8,
RP 81.2 ± 33.6, BP 81.5 ± 20.5, GH 56.7 ± 20.2, VT 52.0 ±
20.9, SF 83.0 ± 17.8, RE 84.4 ± 32.4, and MH 59.7 ± 22.7
[6]. When compared to this normal sample, our sample
showed (at admission) lower mean scores in seven do-
mains for both patients with chronic gastritis and patients
with peptic ulcers (p < 0.001); there was no significant dif-
ference in MH scores for those with chronic gastritis and
higher MH scores than that of the population norm for
those with peptic ulcers.
HRQOL change after treatments
The mean duration of time between pre-and post-
treatment assessments was 8.03 ± 3.85 days for chronicTable 2 Comparisons of mean scores (XS) of domains of CSF
Domains At admission (n = 244)
Chronic gastritis Peptic ulcer t
(n = 124) (n = 120)
PF 78.25 ± 22.97 71.22 ± 28.91 2.10
RP 33.67 ± 39.69 41.60 ± 41.84 −1.5
BP 52.27 ± 20.86 54.93 ± 24.26 −0.9
GH 43.06 ± 19.67 50.29 ± 19.87 −2.8
VT 49.40 ± 21.10 58.29 ± 21.79 −3.2
SF 70.79 ± 23.52 75.56 ± 21.44 −1.6
RE 38.98 ± 41.80 50.42 ± 40.91 −2.1
MH 60.03 ± 20.39 70.30 ± 17.40 −4.2
PCS 93.67 ± 27.10 95.22 ± 31.56 −0.4
MCS 56.89 ± 18.51 65.66 ± 15.65 −3.9
PF: physical function, RP: role-physical, BP: bodily pain, GH: general health, VT: vitali
Component Summary, MCS: Mental Component Summary.
*p < 0.05.gastritis, and 7.11 ± 2.86 days for peptic ulcer. As shown
in Table 3, the mean scores for most domains and for
the two component summaries were significantly diffe-
rent before and after treatment (with the exceptions of
BP and RE for chronic gastritis, and BP, SF, and RE for
peptic ulcers). Overall, HRQOL changed more for pa-
tients with peptic ulcers than for patients with chronic
gastritis, with most domains showing an increase except
for RP in both patients with chronic gastritis and peptic
ulcers. However, the only domains that were significantly
different between the two disease groups were RP, RE,
and MH (p < 0.05). For patients with chronic gastritis,
the domains of PF, GH, and MH, and also the PCS and
MCS, had higher SRM (>0.60) after treatment, indicating
a moderate effect size. A possible reason for this is that
these domains are largely affected by pain, and the pain
was reduced after treatment.
Factors with impact on HRQOL
Results suggest that different domains of HRQOL are in-
fluenced by different socio-demographic variables as well
as disease type (see Table 4). Higher PCS scores tended
to be associated with patients who were married, youn-
ger, and had a higher education and income level.
Higher MCS scores were associated with being male,
having a higher education and income level, and having
a peptic ulcer. For example, the PCS score for the mar-
ried patients was on average 11.95 units higher than that
of the other patients (single, divorced, etc.); the PCS
score for the patients with education level one (primary
school) was on average 11.70 units lower than that of
the patients at education level three (college or higher)
as suggested by the parameter coefficient of −11.70.
Similarly, the MCS score for male patients was on aver-
age 7.78 units higher than that of the female patients;-36 across two diseases at admission and discharge
At discharge (n = 206)
Chronic gastritis Peptic ulcer t
(n = 104) (n = 102)
* 87.65 ± 16.71 83.81 ± 16.63 1.64
2 30.77 ± 38.51 24.75 ± 34.91 1.17
2 51.92 ± 20.02 52.65 ± 22.56 −0.24
6* 51.25 ± 18.71 55.59 ± 18.05 −1.69
4* 55.14 ± 19.31 62.28 ± 15.84 −2.89*
5 74.15 ± 21.70 75.93 ± 18.64 −0.63
6* 46.15 ± 41.88 44.77 ± 40.76 0.24
2* 67.73 ± 18.05 73.69 ± 14.05 −2.64*
1 103.82 ± 24.09 103.35 ± 21.62 0.14
8* 63.19 ± 17.07 68.66 ± 12.05 −2.65*
ty, SF: social function, RE: role-emotional, MH: mental-health, PCS: Physical
Figure 2 Mean scores of domains of CFS-36 at admission across two diseases.
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(primary school) was on average 5.85 units lower than
that of the patients at education level three (college or
higher). However, it is noted that the MCS score for the
patients with chronic gastritis was on average 7.48 units
lower than that of the patients with peptic ulcers, given
the other factors remain stable. This implies that the ef-
fects of the socio-demographic factors on PCS are the
same across the disease types, but the effects of the fac-
tors on MCS scores were different. In other words, the
effects of the factors on MCS were dependent on disease
type, but the effects of the factors on PCS were not
dependent on disease type.Table 3 CSF-36 domain score change after treatment for each
Domains Chronic gastritis
DIF (XS) CR (%)
Physical functioning (PF) 10.10 ± 15.80 12.93
Role-physical (RP) −5.29 ± 26.91# −14.67
Bodily pain (BP) −0.63 ± 15.90 −1.21
General health (GH) 7.26 ± 11.98 16.50
Vitality (VT) 4.23 ± 9.57 8.31
Social functioning (SF) 3.53 ± 15.03 4.99
Role-emotional (RE) 3.21 ± 30.29# 7.46
Mental health (MH) 7.12 ± 11.37# 11.74
PCS 9.61 ± 14.63 10.13
MCS 5.33 ± 8.69 9.21
PCS: Physical Component Summary (weighted sum of PF, RP, BP and GH).
MCS: Mental Component Summary (weighted sum of VT, SF, RE and MH).
DIF: Difference between admission and discharge (scores at discharge minus scores
*p < 0.05 by paired t-test.
#p < 0.05 by independent samples t-test.The influence of the socio-demographic and disease
type factors in predicting PCS and MCS score change
after treatment were different from that above (see
Table 5 in detail). Changes in PCS were influenced by
marriage, age and occupation, whereas changes in MCS
were only influenced by gender and marriage.
Discussions
The role of patient-based symptoms and QOL assessment
in evaluating and treating gastrointestinal disorders has
gained increased attention among gastrointestinal re-
searchers in recent years. We found that patients with
chronic gastritis had lower quality of life compared withdisease
Peptic ulcer
SRM DIF (XS) CR (%) SRM
0.64* 11.25 ± 23.47 15.53 0.48*
0.20* −15.75 ± 38.21# −38.89 0.41*
0.04 1.82 ± 19.76 −3.36 0.09
0.61* 5.69 ± 13.33 11.39 0.43*
0.44* 3.66 ± 15.94 6.25 0.23*
0.23* −0.22 ± 14.24 −0.29 0.02
0.11 −6.27 ± 37.63# −12.26 0.17
0.63* 3.61 ± 12.52# 5.15 0.29*
0.66* 8.05 ± 21.38 8.46 0.38*
0.61* 2.93 ± 10.10 4.46 0.29*
at admission).
Table 4 Factors with impact on HRQOL in patients with chronic diseases selected by the univariate general linear
models
Domains Factors B Std. error t P
Physical Component Summary (PCS) Constant 123.78 7.93 15.61 0.000
Marriage =1 (married) 11.95 5.47 2.13 0.030
Marriage = 2 (other) . . . .
Education = 1 (primary school) −11.70 5.35 −2.19 0.030
Education = 2 (high school) −1.63 4.05 −0.40 0.688
Education = 3 (college or higher) . . . .
Perceived income = 1 (poor) −17.39 6.61 −2.63 0.009
Perceived income = 2 (fair) −7.56 5.93 −1.28 0.203
Perceived income = 3 (high) . . . .
Age −0.60 0.13 −4.66 0.000
Adjusted R Square = 0.14 F = 7.64, P = 0.000
Mental Component Summary (MCS) Constant 68.94 4.05 17.93 0.000
Gender =1 (male) 7.78 2.20 3.53 0.000
Gender = 2 (female) . . . .
Education = 1 (primary school) −5.85 3.01 −1.96 0.050
Education = 2 (high school) 2.38 2.43 0.98 0.328
Education = 3 (college or higher) . . . .
Perceived income = 1 (poor) −14.56 3.38 −3.79 0.000
Perceived income = 2 (fair) −7.66 3.45 −2.22 0.027
Perceived income = 3 (high) . . . .
Disease = 1 (chronic gastritis) −7.48 2.14 −3.50 0.001
Disease = 2 (peptic ulcer) . . . .
Adjusted R Square = 0.17 F = 9.09, P = 0.000
B: Regression coefficient, Std Error: Standard error of Coefficients B.
Categories in bold were as references.
Table 5 Factors with impact on HRQOL change after treatments in patients with chronic diseases selected by the
univariate general linear models
Domains Factors B Std. error t P
Physical Component Summary (PCS) Constant 6.44 4.19 1.54 0.126
Marriage =1 (married) −8.15 3.94 −2.07 0.040
Marriage = 2 (other) . . . .
Occupation =1 (worker) 4.71 2.69 1.75 0.080
Occupation =2 (other) . . . .
Age 0.17 0.09 1.82 0.070
Adjusted R Square = 0.03 F = 2.92, P = 0.035
Mental Component Summary (MCS) Constant 9.96 1.83 5.45 0.000
Gender =1 (male) −2.54 1.30 −1.97 0.050
Gender = 2 (female) . . . .
Marriage =1 (married) −5.09 1.80 −2.82 0.005
Marriage = 2 (other) . . . .
Adjusted R Square = 0.05, F = 5.89, P = 0.003
B: Regression coefficient, Std Error: Standard error of Coefficients B.
Categories in bold were as references.
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both groups had lower quality of life compared with popu-
lation norms (except for MH domain). Both groups expe-
rienced increased QOL after treatments (except for RP
domain for two diseases). Patients who were female, with
lower income, lower education, and older age tended to
have lower quality of life.
Patients with peptic ulcers tended to be older than pa-
tients with chronic gastritis (with mean ages of 46.7 and
43.7, respectively), which may explain the differences be-
tween groups, as increases in age are associated with a
decline in physical functioning and an increase in mental
functioning [15,16]. Another explanation is that the dif-
ferences may be due to gender; there were more women
than men in the chronic gastritis group and more men
than women in the peptic ulcer group. Additionally, pa-
tients with chronic gastritis tended to be in worse health
than those with peptic ulcers when they were hospita-
lized. However, to understand the cause of this, further
study is needed. Future research should further examine
the differences in HRQOL between the two groups as
well as explore possible explanations for the differences.
Past work has shown that patients with chronic disease
tend to have lower mean domain scores than the general
population, due to the symptoms and side effects caused
by treatments [11,17,18]. For example, in Hallerbäck’s
study [11], the results showed that all five patient groups
with digestive diseases reported low general well-being
compared with the general population. When compared
to Chinese population norms [6], our sample also showed
lower mean scores in seven domains for both patients
with chronic gastritis and patients with peptic ulcers, (the
only exception being MH), which supports these existing
findings.
In general, patients with gastrointestinal disorders tend
to have lower QOL than the general population, and
treatment of the disorder can improve QOL [16-21]. For
example, Glise investigated 392 patients with peptic ul-
cers and found that the general QOL score for the
PGWB increased significantly during treatment up until
two weeks post-treatment [21]. The change in domain
scores from admission to discharge reflects not only the
effect of treatment but also the internal responsiveness
of the instrument [13,14]. Table 3 shows that most do-
main scores changed greatly after treatment for both
those with chronic gastritis and peptic ulcers (moderate
and large SRM). The increase in domain scores after
treatment would suggest greater QOL, however for pa-
tients in both disease groups the mean score of role-
physical declined. This decline may be explained by the
nature of the instrument; 4 items (4a, 4b, 4c, 4d) probe
role limitations that are a result of physical health (e.g.,
“Cut down on the amount of time you spent on work or
other activities”). Patients who just spent time in thehospital being treated are likely to respond affirmatively
to these items.
It is notable that some domains (e.g. bodily pain, role-
emotional) had no significant differences after treatment.
Some possible explanations for this are: (1) the observa-
tion period (approximately two weeks) may have been
too short to observe significant changes; (2) some do-
mains may not change over time; (3) insufficient sample
size; and (4) the CSF-36 may not be sensitive enough for
use in work examining chronic disease, as it was deve-
loped for the general population [22].
Lower HRQOL scores have previously been associated
with lower socioeconomic status, educational attain-
ment, and age [23-27]. Our results supported these find-
ings, as HRQOL was related to age, education, marriage,
and disease type, although different domains were influ-
enced by different factors. Overall, patients’ education
level and perceived income were the most influential
factors, as those with a higher education level and with
higher perceived income tended to have higher domain
scores. The reason for this may be that the people with a
higher education level and higher perceived income have
better life conditions. HRQOL scores in patients living
with a spouse were greater than those of patients with-
out a spouse, which may be due to the additional sup-
port a patient may receive from a spouse versus other
family members.
Patients with peptic ulcers tended to have higher scores
on the mental component summary than those with
chronic gastritis after controlling for other factors. There
were also some observed gender effects, as male patients
tended to have higher scores for the mental component
summary after controlling for other factors, which is in ac-
cordance with other findings using the SF-36 [28,29]. Al-
though systematic differences in HRQOL between men
and women is a common finding, very few explanations
or interpretations have been presented as to why this is
the case. It may be that women experience greater, and/or
different, stressors than the men. Ultimately, it is not clear
why the effects of the socio-demographic factors on the
mental component summary scores were dependent on
disease type whereas the effects of the factors on physical
component summary scores were not. Most likely, this is
because there were differences in MCS scores across the
two groups but no differences in PCS scores across the
groups. Further research is needed to investigate the na-
ture of these differences and their associated conse-
quences. The factors influencing HRQOL also impacted
longitudinal change after treatment. Changes in the phy-
sical component summary scores were influenced by mar-
riage, age and occupation, whereas changes in the mental
component summary scores were only influenced by gen-
der and marriage. The reasons for these differences should
be studied further. However, it should be noted that these
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cated by the relatively small adjusted R-squared (0.14 for
PCS and 0.17 for MSC, 0.03 for PCS change and 0.05 for
MCS change). We plan to investigate the effect of clinical
variables such as disease stage, severity, and comorbidities
in future studies.
It is important to note that the participants were only
selected from a hospital and there was a fairly small
sample size, which may be a limitation of the study.
Additional community studies with larger sample sizes
are needed. In addition, this study focused on HRQOL
changes as indicated by statistical significance; however,
clinically meaningful differences were not considered,
which are more important than statistically significant
differences. Our future directions include analyzing the
minimal clinical important difference of QOL scores
for these two diseases by anchor-based methods and
distribution-based methods.
Despite these limitations, we found that patients with
chronic gastritis had lower HRQOL than patients with
peptic ulcers. Both groups had lower HRQOL at admis-
sion than the general population. In general, quality of
life increased after treatment in both groups, and
HRQOL in patients with these two chronic diseases dif-
fered by age, education level, marriage, income, and gen-
der. Patients who were female, with lower income, lower
education, and older age, tended to have a lower quality
of life. Such information could be useful for making
decisions in clinical trials as well as for individual man-
agement and rehabilitation of these diseases [30,31].
Well-executed HRQOL research such as this helps
inform those tasked with health rationing or anyone in-
volved in the decision-making process for agencies such as
the Food and Drug Administration, European Medicines
Agency or National Institute for Clinical Excellence [31].Conclusion
In conclusion, this is the first study to investigate quality
of life and its association with socio-demographic risk
factors among Chinese patients with peptic ulcers and
chronic gastritis. Future studies should investigate why
quality of life is linked to socio-demographic factors and
clinical factors.
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